|
As on
May 15,2026
|
|
Aakaar Medical Techn
|
|
Financial Results/Other business matters
|
|
|
|
Financial Results/Other business matters
|
|
|
|
|
Aarti Drugs
|
|
Audited Results & Quarterly Results
|
|
|
|
Audited Results & Quarterly Results
|
|
|
|
|
Abans Financial
|
|
|
|
Audited Results
|
|
|
|
|
Aether Industries
|
|
Audited Results & Quarterly Results
|
|
|
|
Audited Results & Quarterly Results
|
|
|
|
|
AKI India
|
|
|
|
Audited Results
|
|
|
|
|
Alacrity Securities
|
|
Audited Results & Quarterly Results
|
|
|
|
Audited Results & Quarterly Results
|
|
|
|
|
Alembic Pharma
|
|
Audited Results & Final Dividend
|
|
|
|
Audited Results & Final Dividend
|
|
|
|
|
Amber Enterprises
|
|
|
|
Audited Results
|
|
|
|
|
Anand Rayons
|
|
Audited Results & Quarterly Results
|
|
|
|
Audited Results & Quarterly Results
|
|
|
|
|
Apollo Ingredients
|
|
Audited Results Inter alia, to consider and approve:- 1. To consi
........
|
|
|
|
Audited Results Inter alia, to consider and approve:- 1. To consider and approve the resignation of Mr. James Mody (DIN: 08072328) from the position of Non-Executive Director of the Company. 2. To consider and approve the appointment of Mr. Amol Nirungkar as Independent Director of the Company. 3. To consider and approve the change in designation of Ms. Lovely Ghanshyam Mutreja (DIN: 03307922) from the position of Managing Director of the Company to Executive director (Marketing Director) of the Company on such terms and conditions, including payment of commission not exceeding 2% of sales in lieu of salary. 4. To consider and approve the change in designation of Mr. Kirit Ghanshyam Mutreja (DIN: 07514391) from Executive Director to Managing Director of the Company, on such terms and conditions as may be determined by the Board. 5. Any other matter with the permission of the Chair.
|
|
|
|
|
|